Understanding the cellular populations and mechanisms responsible for overcoming
immune compartmentalization is valuable for designing vaccination strategies targeting …

We sought to assess the degree of cross-protective immunity in a mouse model of
chlamydial genital tract infection. Following resolution of genital infection with the mouse …

ABSTRACT BALB/c mice were vaccinated by the intramuscular (im) and subcutaneous (sc)
routes with a native preparation of the Chlamydia trachomatis mouse pneumonitis (MoPn) …

Determining the effector populations involved in humoral protection against genital
chlamydia infection is crucial to development of an effective chlamydial vaccine. Antibody …

Chlamydia trachomatis sexually transmitted infections cause considerable morbidity and
socioeconomic burden worldwide, despite significant advances in our understanding of the …

Chlamydia trachomatis is the leading cause of preventable blindness and the most common
bacterial sexually transmitted infection. Remarkable progress in vaccine research over the …

Chlamydiae are pathogenic intracellular bacteria that cause a wide variety of diseases
throughout the globe, affecting the eye, lung, coronary arteries and female genital tract …

Chlamydia trachomatis is a major cause of sexually transmitted diseases worldwide. There
is currently no vaccine to protect against chlamydial infection of the female reproductive …

To search for subunit vaccine candidates, immunogenic chlamydial antigens identified in
humans were evaluated for protection against both infection and pathology in a mouse …

Chlamydia trachomatis is the most common sexually transmitted bacterial infection
worldwide. The impact of this pathogen on human reproduction has intensified research …